Quantifying the landscape for development and cancer from a core cancer stem cell circuit

Cancer Research

Volumn 75, Issue 13, 2015, Pages 2607-2618

  Li, Chunhe ^a   Wang, Jin ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL RENEWAL; DEVELOPMENT; GENE ACTIVATION; GENE EXPRESSION; GENE INTERACTION; GENE REGULATORY NETWORK; GENE REPRESSION; HUMAN; MATHEMATICAL MODEL; NEOPLASM; PRIORITY JOURNAL; STEM CELL; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY;

CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MODELS, GENETIC; NEOPLASTIC STEM CELLS;

EID: 84942576109     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0079     Document Type: Article

References (50)

1. Huang S, Guo Y, May G, Enver T. Bifurcation dynamics of cell fate decision lineage-commitment in bipotent progenitor cells. Dev Biol 2007;305:695-713.
2. Van Kampen NG. Stochastic processes in chemistry and physics. 1st ed. Amsterdam: North Holland; 1992.
3. Hu G. Stochastic forces and nonlinear systems. Hao B, editor. Shanghai: Shanghai Scientific and Technological Education Press; 1994.
4. Kauffman S. Differentiation of malignant to benign cells. J Theor Biol 1971;31:429-51.
5. Huang S, Ernberg I, Kauffman S. Cancer attractors: a systems view of tumors from agene network dynamics and developmental perspective. Semin Cell Dev Biol 2009;20:869-76.
6. Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res 2003;63:6212-20.
7. Ao P, Galas D, L H, Zhu X. Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. Med Hypotheses 2008;70:678-84.
8. Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A 2013;110:18144-9.
9. Li C, Wang J. Quantifying the underlying landscape and paths of cancer. J R Soc Interface 2014;10:20140774.
10. Davidson EH. A genomic regulatory network for development. Science 2002;295:1669-78.
11. Chen KC, Csikasz-Nagy A, Gyorffy B, Val J, Novak B, Tyson JJ. Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol Biol Cell 2000;11:369-91.
12. Waddington CH. The strategy of the genes: a discussion of some aspects of theoretical biology. London: Allen and Unwin; 1957.
13. Wang J, Zhang K, Xu L, Wang EK. Quantifying the Waddington landscape and biological paths for development and differentiation. Proc Natl Acad Sci U S A 2011;108:8257-62.
14. Li C, Wang J. Quantifying cell fate decisions for differentiation and reprogramming of a human stem cell network: landscape and biological paths. PLoS Comput Biol 2013;9:e1003165.
15. Wang J, Xu L, Wang EK, Huang S. The potential landscape of genetic circuits imposes the arrow of time in stem cell differentiation. Biophys J 2010; 99:29-39.
16. Xu L, Zhang K, Wang J. Exploring the mechanisms of differentiation, dedifferentiation, reprogramming and transdifferentiation. PLoS ONE 2014;9:e105216.
17. Marotta LLC, Polyak K. Cancer stem cells: a model in the making. Curr Opin Genet Dev 2009;19:44-50.
18. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007;23:675-99.
19. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-84.
20. Sampieri K, Fodde R. Cancer stem cells and metastasis. Semin Cancer Biol 2012;22:187-93.
21. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
22. Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, et al. Cancer stem cell markers in common cancers-therapeutic implications. Trends Mol Med 2008;14:450-60.
23. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011;146:633-44.
24. Polytarchou C, Iliopoulos D, Struhl K. An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state. Proc Natl Acad Sci U S A 2012;109:14470-5.
25. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulatesOCT4, SOX2, and KLF4 and represses pluripotencyinhuman embryonic stem cells. Cell 2009;137:647-58.
26. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011;30:770-82.
27. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011;13:317-23.
28. Zhang J, Sun Q, Zhang Z, Ge S, Han Z, Chen W. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 2012;32:61-9.
29. Jolly MK, Huang B, Lu M, Mani S, Levine H, Ben-Jacob E. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. J R Soc Interface 2014;11:20140962.
30. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
31. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008;9:582-9.
32. Sasai M, Wolynes P. Stochastic gene expression as a many-body problem. Proc Natl Acad Sci U S A 2003;100:2374-9.
33. Wang J, Li C, Wang EK. Potential and flux landscapes quantify the stability and robustness of budding yeast cell cycle network. Proc Natl Acad Sci USA 2010;107:8195-200.
34. Li C, Wang J. Landscape and flux reveal a new global view and physical quantification of mammalian cell cycle. Proc Natl Acad Sci U S A 2014; 111:14130-5.
35. Zhang B, Wolynes PG. Stem cell differentiation as a many-body problem. Proc Natl Acad Sci U S A 2014;111:10185-90.
36. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008;22:894-907.
37. Dip N, Reis ST, Srougi M, Dall'Oglio MF, Leite KR. Expression profile of microRNA-145 in urothelial bladder cancer. Int Braz J Urol 2013;39: 95-102.
38. Aloni-Grinstein R, Shetzer Y, Kaufman T, Rotter V. p53: the barrierto cancer stem cell formation. FEBS Lett 2014;588:2580-9.
39. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460:1132-5.
40. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009;460:1140-4.
41. Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, et al. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008;134:62-73.
42. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 2012;31:4898-911.
43. Trosko JE. From adult stem cells to cancer stem cells. Ann N Y Acad Sci 2006;1089:36-58.
44. Onuchic JN, Wolynes PG. Theory of protein folding. Curr Opin Struct Biol 2004;14:70-5.
45. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2004;7:165-71.
46. Wang J, Xu L, Wang EK. Potential landscape and flux framework of non-equilibrium networks: robustness, dissipation and coherence of biochemical oscillations. Proc Natl Acad Sci U S A 2008;105:12271-6.
47. Wang J, Zhang K, Wang EK. Kinetic paths, time scale, and underlying landscapes: A path integral framework to study global natures of nonequilibrium systems and networks. J Chem Phys 2010;133:125103:1-13.
48. Weinberg RA. The biology of cancer. 1st ed. Beijing: Science Press; 2009.
49. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-51.
50. Lu M, Jolly MK, Onuchic J, Ben-Jacob E. Toward decoding the principles of cancer metastasis circuits. Cancer Res 2014;74:4574-87.